On 2024-9-9 Global Info Research released【Global Biologics Outsourcing Services Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030】. This report includes an overview of the development of the Biologics Outsourcing Services industry chain, the market status of Consumer Electronics (Nickel-Zinc Ferrite Core, Mn-Zn Ferrite Core), Household Appliances (Nickel-Zinc Ferrite Core, Mn-Zn Ferrite Core), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Biologics Outsourcing Services.
Biologics outsourcing services refer to the practice of pharmaceutical and biotechnology companies partnering with external organizations to handle various aspects of the development and manufacturing of biologic drugs. Biologics are complex therapeutic molecules produced using living organisms or their components, such as proteins, antibodies, or nucleic acids.
Outsourcing these services allows companies to leverage the expertise, infrastructure, and resources of specialized contract service providers, often referred to as Contract Development and Manufacturing Organizations (CDMOs) or Contract Research Organizations (CROs).
According to our (Global Info Research) latest study, the global Biologics Outsourcing Services market size was valued at US$ million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of %during review period.
The global demand for biologic drugs continued to rise, driven by factors such as the aging population, increasing prevalence of chronic diseases, and advancements in biotechnology. This heightened demand led to greater outsourcing of biologics development and manufacturing to specialized service providers.
The development and approval of biosimilar drugs, which are highly similar versions of approved biologic drugs, gained momentum. As biosimilars offer cost-effective alternatives to branded biologics, there was a growing need for outsourcing services to support biosimilar development, including analytical testing, process development, and manufacturing.
This report is a detailed and comprehensive analysis for global Biologics Outsourcing Services market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
Sample Report Request Biologics Outsourcing Services
https://www.globalinforesearch.com/reports/2058894/biologics-outsourcing-services
Market segment by Type： Cell and Gene Therapies、Antibodies、Vaccines、Other
Market segment by Application：SMBs、Large Companies
Major players covered： Lonza、Catalent、Samsung Biologics、FUJIFILM Diosynth Biotechnologies、Boehringer Ingelheim、WuXi AppTech、Recipharm、Thermo Fisher Scientific、AGC Biologics、Rentschler Biopharma、KBI Biopharma、Siegfried、Aenova Group
Market segment by region, regional analysis covers: North America (United States, Canada and Mexico), Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe), Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia),South America (Brazil, Argentina, Colombia, and Rest of South America),Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa).
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Biologics Outsourcing Services product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Biologics Outsourcing Services, with price, sales, revenue and global market share of Biologics Outsourcing Services from 2019 to 2024.
Chapter 3, the Biologics Outsourcing Services competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Biologics Outsourcing Services breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Biologics Outsourcing Services market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Biologics Outsourcing Services.
Chapter 14 and 15, to describe Biologics Outsourcing Services sales channel, distributors, customers, research findings and conclusion.
Data Sources:
About Us:
GlobaI Info Research
Web: https://www.globalinforesearch.com
CN: 0086-176 6505 2062
HK: 00852-58030175
US: 001-347 966 1888
Email: report@globalinforesearch.com
Global Info Research is a company that digs deep into global industry information to support enterprises with market strategies and in-depth market development analysis reports. We provides market information consulting services in the global region to support enterprise strategic planning and official information reporting, and focuses on customized research, management consulting, IPO consulting, industry chain research, database and top industry services. At the same time, Global Info Research is also a report publisher, a customer and an interest-based suppliers, and is trusted by more than 30,000 companies around the world. We will always carry out all aspects of our business with excellent expertise and experience.